Professor of Bioengineering, Univ. of Pittsburgh; RiMED Head of Cardiovascular Tissue Engineering Lab. Univ. of Palermo. CTO at Neoolife.
Pittsburgh, USA
Joined August 2012
- Tweets282
- Following497
- Followers301
- Likes1.4K
Antonio D'Amore retweeted
Innovation Begins with a Question. Impact Begins with the Courage to Find an Answer.
Congratulations to @macky_neal , on his inspiring reflection published in the American College of Surgeons Bulletin, “A Surgeon-Scientist Reflects on Nearly a Decade of Innovation.”
From pioneering research in platelet biology to advancing synthetic platelet technology that could transform emergency trauma care, Dr. Neal's journey is a powerful reminder that the most meaningful innovations begin with a commitment to solving real human challenges.
His work represents the extraordinary intersection of science, medicine, entrepreneurship, mentorship, and visionary leadership demonstrating how discoveries in the laboratory can move toward life-saving solutions for patients around the world.
What makes this journey especially inspiring is his belief that innovation is not simply about scientific breakthroughs, but about building the teams, institutions, and next generation of leaders who can carry those breakthroughs forward.
The future of healthcare will be shaped by leaders who dare to challenge what is possible and remain deeply committed to the people they serve.
Congratulations, Dr. Neal, on nearly a decade of remarkable progress and on the exciting possibilities ahead.
Read the full article: facs.org/for-medical-profess…
#PittSurgery #SurgeonScientist #TraumaSurgery #Mentorship #SurgicalInnovation #ACSJacobsonAward
@AmCollSurgeons @UPMC_SurgRes @UPMC
🤖 Made with AI
Grateful to receive the 2026 University of Pittsburgh Health Sciences Ascending Star Award and to deliver my lecture on biomimicry in cardiovascular tissue engineering.
A recognition I share with colleagues across Pitt, Ri.MED and UNIPA who made this possible.
Antonio D'Amore retweeted
"We're incredibly excited to be partnering with Italy," said @UnderSecE Jacob Helberg.
The launch of the Accelerator follows a joint statement by Prime Minister @GiorgiaMeloni and @POTUS Trump on trusted tech, and a critical mineral memorandum signed by @Antonio_Tajani @SecRubio.
Antonio D'Amore retweeted
Congrats to Dr. Samuel Licata on completing his 1,500th robotic-assisted surgery at UPMC Trinity! 🩺
This milestone underscores UPMC Trinity's commitment to bringing advanced, minimally invasive surgical innovation to the local community. Robotic systems offer enhanced precision, smaller incisions & faster recovery times for patients!
Read more about this milestone: upmc.com/media/news/101226-u…
#MedTech #RoboticSurgery #UPMCTrinity
@UPMC
🤖 Made with AI
Antonio D'Amore retweeted
Congratulations!
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2026 Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel to Robert E. Hall and Michael Woodford “for microeconomic foundations of macroeconomic stabilisation.”
#NobelPrize
Antonio D'Amore retweeted
In 1992 Peter Ratcliffe received this rejection from Nature.
Almost 30 years later he won the Nobel Prize for the same discovery.
Don't lose faith in the things you believe in.
Antonio D'Amore retweeted
A new milestone for Symvess® in Florida.
Last week, Dr. Geoff Risley of Coastal Vascular and Interventional performed the first commercial Symvess® case at Sacred Heart Emerald Coast in Destin.
Thank you to Dr. Risley and the entire clinical team for helping to expand access to this important treatment option for patients.
#HealthcareInnovation #MedicalExcellence
PLEASE SEE IMPORTANT SAFETY INFORMATION INCLUDING THE BOXED WARNING, AND FULL PRESCRIBING INFORMATION at bit.ly/4dl5tuL
INDICATION
SYMVESS is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible.
GRAFT FAILURE: loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life-threatening hemorrhage.
DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy after acute injury resolution.
WARNINGS AND PRECAUTIONS: Vascular Graft Rupture, Anastomotic Failure, and Thrombosis have occurred in patients treated with SYMVESS. SYMVESS is manufactured using cells and reagents that may transmit infectious diseases or agents; none have been reported during clinical testing.
ADVERSE REACTIONS: most common (≥3%): thrombosis, fever, pain, anastomotic stenosis, rupture or anastomotic failure, and infection.
Antonio D'Amore retweeted
🇮🇹🤝🇺🇸 Italian American Heritage Month celebrates the bond between Italy and the United States, rooted in historic trade and business ties.
Let's celebrate the many Italian companies operating and investing in the United States!
Antonio D'Amore retweeted
Member publication alert:
Bioprosthetic heart valve degeneration: new insights into structural remodeling and calcification
frontiersin.org/journals/car…
Antonio D'Amore retweeted
We now have 100 covers in Advanced Materials! 🎉
Thank you to the 80+ research groups who trusted us with their science, and to the editors for picking them.
Got a paper coming out? We would love to make its cover.
Antonio D'Amore retweeted
🎉 Heading to the @AmCollSurgeons Clinical Congress 2026 in Washington, D.C.!
We're proud to share that Timothy R. Billiar, MD, FACS — George Vance Foster Professor and Chair of Surgery at @PittSurgery — is the 2026 honoree of the Wangensteen Scientific Forum Award, one of the most prestigious honors in surgical research, recognizing a surgeon's lifetime achievement in innovation and mentorship.
📅 Mon, Sept 28 | 8:00–9:30 AM ET | Room 207A
Join us in celebrating this well-deserved honor — congratulations, Dr. Billiar! 👏
🔗 facs.org/for-medical-profess…
#ACSClinicalCongress2026 #ACS2026 #SurgicalResearch #PittSurgery
@UPMC_SurgRes @UPMC @HviUpmc @UPMC_Vascular @PittNeurosurg @InstituteStarzl @PittTweet
Tonight on Radio 24 – Smart City with Maurizio Melis, talking about research, innovation and their impact beyond the lab.
radio24.ilsole24ore.com/prog…
8:45 PM CET
Podcast available tomorrow.
#Radio24 #SmartCity #Research #Innovation
Frontier research, scientific excellence and long-term competitiveness are part of the same ecosystem.
A valuable discussion at the Italian Chamber of Deputies with ERC in Italy, bringing researchers and institutions together around the future of research in Italy.
#ERCinItaly
Antonio D'Amore retweeted
Another Italian company, aluminum die casting company 2A USA (2ausa.com/, a subsidiary of Fonderie 2A), is growing in the United States with a $32 million investment in Alabama.
Italy 🇮🇹-US🇺🇸 bonds continue to grow stronger!
governor.alabama.gov/newsroo…
Antonio D'Amore retweeted
And it's finally out!!!
nature.com/articles/s41467-0…
go.nature.com/4fuaJzW
Congrats to first author @moisesdisante and the research teams at @LabPhysiology @berteroale and
@florianjug.
Tnx to the editor and reviewers of the manuscript for helping us make the paper better than the preprint (e.g., pro-proliferative screening in the last figure).
And tnx to various collaborators who have already asked us for reagents and cells to make CALIPERS work in their labs - reach out if you want to give it a try!
🚀 CALIPERS v2 preprint is locked—journal submission next. Final polish, more hiPSC reference lines, and fresh light-sheet data. Still, a great collaboration led by @moisesdisante with the team @LabPhysiology and the amazing @berteroale and @florianjug group members!
doi.org/10.1101/2024.12.19.6…
Antonio D'Amore retweeted
Semestre filtro per l'ingresso a Medicina, al via le iscrizioni: dalla didattica ai test, tutte le novità di quest'anno ift.tt/My5PqkX
Looking forward to hosting Prof. Abdul I. Barakat (Institut Polytechnique de Paris & Duke University) for the next Ri.MED Research Seminar.
📅 Sept. 8, 2026 | 📍 ISMETT, Palermo
Registration: lnkd.in/d4qB7pii
🤖 Made with AI
We’re hiring at the D’Amore Laboratory, this position is fully Pitt and USA based.
Join our work in cardiovascular tissue engineering, biomaterials, and translational bioengineering.
Apply here:
cfopitt.taleo.net/careersect…
Please share with qualified candidates.
